Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Zevaskyn (prademagene zamikeracel) Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa
Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the U.S. Food and Drug Administration (FDA) has approved Zevaskyn (pronounced as ‘ZEE-vah-skin’)...
FDA Approves Penpulimab-kcqx for the Treatment of Advanced Nasopharyngeal Carcinoma
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the U.S. Food and Drug Administration (FDA) has approved its differentiated...
Milwaukee Closes More Schools to Address Lead Crisis
WEDNESDAY, April 30, 2025 — Milwaukee will temporarily close two more elementary schools as it works to tackle a lead crisis in its public school buildings.The...
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a return...
Lorundrostat Beneficial for BP Reduction in Uncontrolled Hypertension
For patients with uncontrolled and treatment-resistant hypertension, lorundrostat is associated with greater reductions in blood pressure than placebo,...
Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists
Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2 inhibitors...
Statin Use Improves Outcomes in Chronic, Small Lymphocytic Leukemia
For patients with chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL), statin use is associated with improved survival, regardless...
New HHS Ad Campaign Urges Americans to 'Take Back Your Health'
WEDNESDAY, April 30, 2025 — U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is preparing to launch a multimillion-dollar public health...
Martinelli Recalls 170,000 Apple Juice Bottles for Possible Toxin
WEDNESDAY, April 30, 2025 — More than 170,000 bottles of Martinelli’s apple juice are being recalled due to possible contamination with a mold-related...
More Kids Without Asthma Inhaler After Popular Product Taken Off Market
WEDNESDAY, April 30, 2025 — More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler,...
Where Have All The Insects Gone — And Why?
SATURDAY, April 26, 2025 — From beetles to moths, leafhoppers and butterflies, the world's insects are vanishing at a breakneck pace. Since 2017,...
Recently Added
Recently added consumer and prescribing information: Miudella, Opdivo Qvantig, Alyftrek, Crenessity, Ensacove, Steqeyma, Yesintek, Revuforj, Danziten, Aucatzyl
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex CareNotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Zevaskyn Zevaskyn (prademagene zamikeracel) is an autologous, cell sheet-based gene therapy for the treatment of recessive dystrophic epidermolysis bullosa.
- Penpulimab-kcqx is a programmed death receptor-1 (PD-1)-blocking antibody for use in the treatment of nasopharyngeal carcinoma.
- Jobevne Jobevne (bevacizumab-nwgd) is a vascular endothelial growth factor inhibitor biosimilar to Avastin used for the treatment of colorectal...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...